Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies (RRTdose)
Pharmacokinetics and Deposition of Commonly Prescribed Antibiotics in Hospitalized Critically Ill Patients Undergoing Renal Replacement Therapies
Sponsor: Cleveland Clinic Abu Dhabi
Listed as NCT03636464, this observational or N/A phase trial focuses on Renal Replacement Therapy and remains actively recruiting participants. Sponsored by Cleveland Clinic Abu Dhabi, it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
-
Dec 2021 — Mar 2023 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Sep 2020 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Sep 2018 — Sep 2020 [monthly]
Recruiting
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cleveland Clinic Abu Dhabi
- University of the Sciences in Philadelphia
For direct contact, visit the study record on ClinicalTrials.gov .